Association of gender and race with allocation of advanced heart failure therapies
K Breathett, E Yee, N Pool, M Hebdon… - JAMA network …, 2020 - jamanetwork.com
Importance Racial bias is associated with the allocation of advanced heart failure therapies,
heart transplants, and ventricular assist devices. It is unknown whether gender and racial …
heart transplants, and ventricular assist devices. It is unknown whether gender and racial …
Does race influence decision making for advanced heart failure therapies?
K Breathett, E Yee, N Pool, M Hebdon… - Journal of the …, 2019 - Am Heart Assoc
Background Race influences medical decision making, but its impact on advanced heart
failure therapy allocation is unknown. We sought to determine whether patient race …
failure therapy allocation is unknown. We sought to determine whether patient race …
Racial inequities in access to ventricular assist device and transplant persist after consideration for preferences for care: a report from the REVIVAL study
TM Cascino, MM Colvin, DE Lanfear… - Circulation: Heart …, 2023 - Am Heart Assoc
Background: Racial disparities in access to advanced therapies for heart failure (HF)
patients are well documented, although the reasons remain uncertain. We sought to …
patients are well documented, although the reasons remain uncertain. We sought to …
Factors associated with racial and ethnic diversity among heart failure trial participants: a systematic bibliometric review
S Wei, NC Le, JW Zhu, K Breathett… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: Heart failure has a disproportionate burden on patients who are Black,
Indigenous, and people of color (BIPOC), but not much is known about representation of …
Indigenous, and people of color (BIPOC), but not much is known about representation of …
Global variations according to sex in patients hospitalized for heart failure in the REPORT-HF registry
Background Previous reports suggest that risk factors, management, and outcomes of acute
heart failure (AHF) may differ by sex, but they rarely extended analysis to low-and middle …
heart failure (AHF) may differ by sex, but they rarely extended analysis to low-and middle …
Improving enrollment of underrepresented racial and ethnic populations in heart failure trials: a call to action from the heart failure collaboratory
EM DeFilippis, M Echols, PB Adamson… - JAMA …, 2022 - jamanetwork.com
Importance Despite bearing a disproportionate burden of heart failure (HF), Black and
Hispanic individuals have been poorly represented in HF clinical trials. Underrepresentation …
Hispanic individuals have been poorly represented in HF clinical trials. Underrepresentation …
Racial and ethnic disparities in heart failure: current state and future directions
SC Lewsey, K Breathett - Current opinion in cardiology, 2021 - journals.lww.com
Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization
rates from heart failure. In spite of improved therapies and overall survival, the mortality …
rates from heart failure. In spite of improved therapies and overall survival, the mortality …
Evaluation of racial and ethnic disparities in cardiac transplantation
Background Racial and ethnic disparities contribute to differences in access and outcomes
for patients undergoing heart transplantation. We evaluated contemporary outcomes for …
for patients undergoing heart transplantation. We evaluated contemporary outcomes for …
[HTML][HTML] Representation of women in heart failure clinical trials: barriers to enrollment and strategies to close the gap
Heart failure is a significant public health burden that differentially impacts women. Important
sex-and gender-based differences in HF risk factors, presentation, and treatment exist, and …
sex-and gender-based differences in HF risk factors, presentation, and treatment exist, and …
Sex, racial, and ethnic disparities in US cardiovascular trials in more than 230,000 patients
O Preventza, A Critsinelis, K Simpson, JK Olive… - The Annals of Thoracic …, 2021 - Elsevier
Background The current representation of female patients and racial and ethnic minorities in
cardiovascular trials is unclear. We evaluated these groups' inclusion in US cardiovascular …
cardiovascular trials is unclear. We evaluated these groups' inclusion in US cardiovascular …